{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T04:24:11Z","timestamp":1772943851627,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T00:00:00Z","timestamp":1750809600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T00:00:00Z","timestamp":1750809600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002964","name":"\u00c7ukurova \u00dcniversitesi","doi-asserted-by":"publisher","award":["TTU-2022-14602"],"award-info":[{"award-number":["TTU-2022-14602"]}],"id":[{"id":"10.13039\/501100002964","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Mol Morphol"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Soft tissue sarcomas are heterogenous groups of tumors that show variable morphology as well as clinical behavior. Morphological features do not always directly reflect clinical behavior. Certain mesenchymal tumors exhibit an indolent clinical course. Among them are superficial CD34-positive fibroblastic tumors characterized by PRDM10 fusion. In our study, we aimed to detect PRDM10 gene rearrangement in superficial CD34-positive fibroblastic tumors and other pleomorphic sarcomas included in its differential diagnosis by immunohistochemistry and Fluorescence in situ hybridization. Totally, 33 cases were enrolled into this study. The results showed that two cases diagnosed as superficial CD34-positive fibroblastic tumor and two cases diagnosed as undifferentiated pleomorphic sarcoma have PRDM10 gene rearrangement. Immunohistochemically, not all rearranged tumors showed PRDM10 staining that suggests a low sensitivity of PRDM10 antibody. In conclusion, we suggested that PRDM10 gene rearrangement is not limited to superficial CD34-positive fibroblastic tumors; undifferentiated pleomorphic sarcomas may exhibit this molecular alteration and immunohistochemistry has lower sensitivity than fluorescence in situ hybridization.<\/jats:p>","DOI":"10.1007\/s00795-025-00442-2","type":"journal-article","created":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T04:14:15Z","timestamp":1750824855000},"page":"20-25","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of PRDM10 gene rearrangement by immunohistochemistry and molecular methods in unclassifiable undifferentiated soft tissue tumors"],"prefix":"10.1007","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9212-3256","authenticated-orcid":false,"given":"Merve","family":"Aksin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4951-8703","authenticated-orcid":false,"given":"Kivilcim Eren","family":"Ates","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9686-4991","authenticated-orcid":false,"given":"Akif","family":"Mirioglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9135-0265","authenticated-orcid":false,"given":"Tugba","family":"Toyran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3065-1683","authenticated-orcid":false,"given":"Gulfiliz","family":"Gonlusen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,25]]},"reference":[{"key":"442_CR1","volume-title":"Soft tissue and bone tumours WHO classification of tumours","author":"WCoTE B","year":"2020","unstructured":"WCoTE B (2020) Soft tissue and bone tumours WHO classification of tumours, vol 3, 5th edn. IARC Publications, Lyon","edition":"5"},{"issue":"1","key":"442_CR2","first-page":"107","volume":"2","author":"E Di Zazzo","year":"2013","unstructured":"Di Zazzo E, De Rosa C, Abbondanza C, Moncharmont B (2013) PRDM Proteins: molecular mechanisms in signal transduction and transcriptional regulation. Biology (Basel) 2(1):107\u2013141","journal-title":"Biology (Basel)"},{"key":"442_CR3","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.gde.2016.03.009","volume":"36","author":"S Mzoughi","year":"2016","unstructured":"Mzoughi S, Tan YX, Low D, Guccione E (2016) The role of PRDMs in cancer: one family, two sides. Curr Opin Genet Dev 36:83\u201391","journal-title":"Curr Opin Genet Dev"},{"key":"442_CR4","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.bbagrm.2018.06.002","volume":"1861","author":"A Sorrentino","year":"2018","unstructured":"Sorrentino A, Rienzo M, Ciccodicola A, Casamassimi A, Abbondanza C (2018) Human PRDM2: structure, function and pathophysiology. Biochim Biophys Acta Gene Regul Mech 1861:657\u2013671","journal-title":"Biochim Biophys Acta Gene Regul Mech"},{"issue":"1","key":"442_CR5","doi-asserted-by":"publisher","first-page":"29","DOI":"10.5483\/BMBRep.2010.43.1.029","volume":"43","author":"JA Park","year":"2010","unstructured":"Park JA, Kim KC (2010) Expression patterns of PRDM10 during mouse embryonic development. BMB Rep 43(1):29\u201333","journal-title":"BMB Rep"},{"issue":"2","key":"442_CR6","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/modpathol.2013.139","volume":"27","author":"JM Carter","year":"2014","unstructured":"Carter JM, Weiss SW, Linos K, DiCaudo DJ, Folpe AL (2014) Superficial CD34-positive fibroblastic tumor: report of 18 cases of a distinctive low-grade mesenchymal neoplasm of intermediate (borderline) malignancy. Mod Pathol 27(2):294\u2013302","journal-title":"Mod Pathol"},{"issue":"3","key":"442_CR7","doi-asserted-by":"publisher","first-page":"377","DOI":"10.4103\/IJPM.IJPM_589_16","volume":"60","author":"N Sood","year":"2017","unstructured":"Sood N, Khandelia BK (2017) Superficial CD34-positive fibroblastic tumor: a new entity; case report and review of literature. Indian J Pathol Microbiol 60(3):377\u2013380","journal-title":"Indian J Pathol Microbiol"},{"issue":"1","key":"442_CR8","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.lungcan.2014.10.012","volume":"87","author":"S Scarpino","year":"2015","unstructured":"Scarpino S, Pulcini F, Di Napoli A, Giubettini M, Ruco L (2015) EGFR mutation testing in pulmonary adenocarcinoma: evaluation of tumor cell number and tumor percent in paraffin sections of 120 small biopsies. Lung Cancer 87(1):8\u201313","journal-title":"Lung Cancer"},{"issue":"4","key":"442_CR9","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1097\/PAS.0000000000001207","volume":"43","author":"F Puls","year":"2019","unstructured":"Puls F, Pillay N, Fagman H, Palin-Masreliez A, Amary F, Hansson M et al (2019) PRDM10-rearranged soft tissue tumor: a clinicopathologic study of 9 cases. Am J Surg Pathol 43(4):504\u2013513","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"442_CR10","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1111\/his.14429","volume":"79","author":"R Perret","year":"2021","unstructured":"Perret R, Michal M, Carr RA, Velasco V, \u0160vajdler M, Karanian M et al (2021) Superficial CD34-positive fibroblastic tumor and PRDM10-rearranged soft tissue tumor are overlapping entities: a comprehensive study of 20 cases. Histopathology 79(5):810\u2013825","journal-title":"Histopathology"},{"issue":"6","key":"442_CR11","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/s41379-021-00991-8","volume":"35","author":"F Puls","year":"2022","unstructured":"Puls F, Carter JM, Pillay N, McCulloch TA, Sumathi VP, Rissler P et al (2022) Overlapping morphological, immunohistochemical and genetic features of superficial CD34-positive fibroblastic tumor and PRDM10-rearranged soft tissue tumor. Mod Pathol 35(6):767\u2013776","journal-title":"Mod Pathol"},{"issue":"4","key":"442_CR12","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1093\/ajcp\/aqac171","volume":"159","author":"M Zhao","year":"2023","unstructured":"Zhao M, Yin X, He H, Fan Y, Ru G, Meng X (2023) Recurrent PRDM10 fusions in superficial CD34-positive fibroblastic tumors\u202f: a clinicopathologic and molecular study of 10 additional cases of an emerging novel entity. Am J Clin Pathol 159(4):367\u2013378","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"442_CR13","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1158\/1078-0432.CCR-14-2399","volume":"21","author":"J Hofvander","year":"2015","unstructured":"Hofvander J, Tayebwa J, Nilsson J, Magnusson L, Brosj\u00f6 O, Larsson O et al (2015) Recurrent PRDM10 gene fusions in undifferentiated pleomorphic sarcoma. Clin Cancer Res 21(4):864\u2013869","journal-title":"Clin Cancer Res"},{"issue":"1","key":"442_CR14","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s00795-022-00341-w","volume":"56","author":"S Sugita","year":"2023","unstructured":"Sugita S, Takenami T, Kido T, Aoyama T, Hosaka M, Segawa K et al (2023) Usefulness of SynCAM3 and cyclin D1 immunohistochemistry in distinguishing superficial CD34-positive fibroblastic tumor from its histological mimics. Med Mol Morphol 56(1):69\u201377","journal-title":"Med Mol Morphol"},{"issue":"3","key":"442_CR15","doi-asserted-by":"publisher","first-page":"223","DOI":"10.5114\/pjp.2022.124490","volume":"73","author":"O Mistik","year":"2022","unstructured":"Mistik O, Sayar H (2022) Immunohistochemical positive regulatory domain member 10 expression in soft tissue sarcomas. Pol J Pathol 73(3):223\u2013232","journal-title":"Pol J Pathol"},{"issue":"4","key":"442_CR16","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1002\/path.5326","volume":"249","author":"J Hofvander","year":"2019","unstructured":"Hofvander J, Puls F, Pillay N, Steele CD, Flanagan AM, Magnusson L et al (2019) Undifferentiated pleomorphic sarcomas with PRDM10 fusions have a distinct gene expression profile. J Pathol 249(4):425\u2013434","journal-title":"J Pathol"},{"issue":"4","key":"442_CR17","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.jos.2017.02.004","volume":"22","author":"S Sugita","year":"2017","unstructured":"Sugita S, Hasegawa T (2017) Practical use and utility of fluorescence in situ hybridization in the pathological diagnosis of soft tissue and bone tumors. J Orthop Sci 22(4):601\u2013612","journal-title":"J Orthop Sci"},{"issue":"4","key":"442_CR18","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s12253-017-0200-z","volume":"23","author":"G Papp","year":"2017","unstructured":"Papp G, Mih\u00e1ly D, S\u00e1pi Z (2017) Unusual signal patterns of break-apart FISH probes used in the diagnosis of soft tissue sarcomas. Pathol Oncol Res 23(4):863\u2013871","journal-title":"Pathol Oncol Res"}],"container-title":["Medical Molecular Morphology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00795-025-00442-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00795-025-00442-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00795-025-00442-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T12:51:42Z","timestamp":1772887902000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00795-025-00442-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,25]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["442"],"URL":"https:\/\/doi.org\/10.1007\/s00795-025-00442-2","relation":{},"ISSN":["1860-1480","1860-1499"],"issn-type":[{"value":"1860-1480","type":"print"},{"value":"1860-1499","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,25]]},"assertion":[{"value":"29 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There is no conflict of interests for all authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Our project has been approved by the Non-Interventional Research Ethics Committee of Cukurova University Faculty of Medicine with the letter specified in the decision number 30 of the meeting dated November 5, 2021. Samples were anonymized, waiving the need for informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and \u0131nformed consent"}}]}}